Abstract
In the current pandemic of COVID-19, kidney transplant recipients with COVID-19 are at an additional risk of contracting mucormycosis and other infections. Rarely, coinfection of COVID-19 and mucormycosis in kidney transplant recipient may occur, which poses challenges in the management. Mucormycosis is caused by a fungus of Mucorales family. Delayed identification and management are associated with a higher mortality. High index of suspicion is needed for timely interventions. We report a case of COVID-19 coinfection with mucormycosis in a kidney transplant recipient. Timely treatment with antifungal drugs like liposomal amphotericin B with surgical debridement helped cure the patient and prevent damage to the brain.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Indira Gandhi Institute Of Medical Sciences
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
